Public concerns about Johnson & Johnson’s coronavirus vaccine are widespread, according to post-ABC polls.

As the country emerges from the Johnson & Johnson 10-day suspension, its attitudes towards vaccine safety will change dramatically.

Adrian Colon, 48-year-old commercial loan officer, has not received a shot Still, his age group wasn’t yet qualified when he last checked at the Mayo Clinic near his home in Glendale, Arizona a few weeks ago. He was paying attention throughout the pandemic, he said, leaving home to get groceries and taking his two teenagers from his ex-wife with whom he shares custody. Another “artist, lonely type” who picks him up and practices several times a month in a rock band where he plays bass.

Colon believes he has been well protected from the harm from the virus, but he will be “most certainly” vaccinated. “I believe in science,” he said. “That’s really important.”

If the Johnson & Johnson vaccine was available at the time of booking, he said, “I will take it.” He knows of reports of blood clots, but he does not belong to the group of women of childbearing age who explained the first six reported cases that prompted a pause in a man close to 50 years old, he said. Told.

“Any of the three [vaccines] To be honest, it’s good for me, “Collon said.

Meanwhile, Catherine Young, a former sergeant at the Philadelphia Police Department, said that if she was given the Johnson & Johnson vaccine, “I would decline it.”

The 62-year-old Young, who spends days with babysitters for his toddler grandchildren, said he plans to be vaccinated primarily “for friends and family.” Many things that “must be vaccinated” are stuck. “

She thinks she has a coronavirus antibody. In February 2020, Young and her husband were one of the first waves of people in the United States to develop covid-19, a disease caused by the virus.

“I was the most ill in my life,” Young recalled. “Several times I thought,’I’m not going to get through this.'”

She did not go to the hospital and was treated by a doctor with steroids and a nebulizer. In the second week of her illness, one of her five children, a 27-year-old daughter, happened to lose her IT job and came back to bring young toast and urge her to eat. I did.She was sick About 1 month. I had a prolonged cough.

Young and her husband have recovered. She does not intend to get the vaccine in a hurry. We hope to have more information about how long the protection from shots will last and whether boosters are needed. “I don’t know if they are as effective as they should be,” she said.

Still, she is willing to get vaccinated, but not with Johnson & Johnson products.

“It was the blood clot that everyone was talking about,” Young said. “I wasn’t very keen on it.”

Peter Hotez, a professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine in Houston, said whether such vigilance would persist: “How the CDC and FDA are currently responding to this. It depends on the virus. ” “If you mess this up in a message way, the consequences aren’t that devastating to the United States,” he said. shot.

However, Hotez said: .. .. .. Avoiding vaccine rejection is very urgent in Africa, Latin America and the Middle East. “

Angela Rasmussen, a research scientist at the Institute of Virology At the University of Saskatchewan, Canada, the suspension of Johnson & Johnson has agreed that it could adversely affect countries receiving injections through the international vaccine alliance Covax. It relies primarily on that vaccine and the vaccine from AstraZeneca, which is associated with rare coagulation episodes.

“If people in these countries think, you are giving us a dangerous vaccine and maintaining a better vaccine. [yourselves]That way, you won’t be vaccinated, “says Rasmussen.

Nonetheless, she said the suspension was “perfectly appropriate,” even if regulators ultimately determined that the benefits of the vaccine outweighed the risks. The fact that manufacturers reported the first few cases of blood clots, and federal health authorities took them seriously and warned clinicians, is that the public that “the precautions we are taking are working.” Should increase your trust.

Post-ABC News polls were conducted by phone on a random national sample of 1,007 adults, 75% on mobile phones and 25% on landlines. The results have an error of plus or minus 3.5 percentage points across the sample.

Emily Guskin contributed to this report.